Abstract
Neoadjuvant chemotherapy has become the standard treatment for patients with locally advanced breast cancer; however a technique that can accurately differentiate responders from non-responders at an early time point during treatment has still to be identified. The purpose of this work was to evaluate the ability of pharmacokinetically modelled dynamic contrast-enhanced MRI data to predict and monitor response of patients diagnosed with locally advanced breast cancer to neoadjuvant chemotherapy, at an early time point during treatment. Sixty-eight patients with histology proven breast cancer underwent MRI examination prior to treatment, early during treatment and following the final cycle of chemotherapy. A two compartment pharmacokinetic model provided the kinetic parameters transfer constant (Ktrans), rate constant (Kep) and extracellular extravascular space (Ve) for a region of interest encompassing the whole lesion (ROIwhole) and a 3 × 3 pixel ‘hot-spot’ showing the greatest mean maximum percentage enhancement from within that region (ROIhs). Following treatment 48 patients were classified as responders and 20 as non-responders based on total tumour volume reduction. Tumour volume changes between the pre-treatment and early treatment time points demonstrated differences between responders and non-responders with percentage change revealing the most significant result (p < 0.001). Analysis based on ROIhsprovided more statistically significant differences between responders and non-responders then ROIwhole analysis. ROIhs analysis demonstrated differences between responders and non-responders both prior to and early during treatment. A highly significant reduction in both Ktrans and Kep (p < 0.001) was noted for responders between the pre-treatment and early treatment time points, while Ve significantly increased during the same time period for non-responders (p < 0.001). Quantification of dynamic contrast enhancement parameters provides a potential means for differentiating responders from non-responders early during their treatment, thereby allowing a prompt change in treatment if necessary.
Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
DJ Booser GN. Hortobagyi (1992) ArticleTitleTreatment of locally advanced breast-cancer Semin Oncol 19 IssueID3 278–285 Occurrence Handle1:STN:280:DyaK38zgt1ymsg%3D%3D Occurrence Handle1609294
HM Kuerer LA Newman AU Buzdar K Dhingra KK Hunt TA Buchholz SM Binkley EA Strom FC Ames MI Ross BW Feig McNeese GN Hortobagyi SE. Singletary (1998) ArticleTitlePathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status Cancer J Scientific Am 4 IssueID4 230–236 Occurrence Handle1:STN:280:DyaK1czlsVCgtw%3D%3D
HM Kuerer SE Singletary AU Buzdar FC Ames V Valero TA Buchholz MI Ross L Pusztai GN Hortobagyi KK. Hunt (2003) ArticleTitleSurgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma Am J Surg 182 IssueID6 601–608 Occurrence Handle10.1016/S0002-9610(01)00793-0
LD Feldman GN Hortobagyi AU Buzdar FC Ames GR. Blumenschein (1986) ArticleTitlePathological assessment of response to induction chemotherapy in breast-cancer Cancer Res 46 IssueID5 2578–2581 Occurrence Handle1:STN:280:DyaL287ovFGkuw%3D%3D Occurrence Handle3697997
VF Cocquyt GM Villeirs PN Blondeel HT Depypere MM Mortier RF Serreyn R Broecke ParticleVanDen SJP Belle ParticleVan (2002) ArticleTitleAssessment of response to preoperative chemotherapy in patients with stage II and III breast cancer: the value of MRI Breast 11 IssueID4 306–315 Occurrence Handle10.1054/brst.2002.0450
R Gilles JM Guinebretiere C Toussaint M Spielman M Rietjens JY Petit G. Contesso (1994) ArticleTitleLocal advanced breast-cancer – Contrast-enhanced subtraction MR-imaging of response to preoperative chemotherapy Radiology 191 IssueID3 633–638 Occurrence Handle1:STN:280:DyaK2c3ktValuw%3D%3D Occurrence Handle8184039
G Trecate E Ceglia F Stabile JD Tesoro-Tess G Mariani M Zambetti R. Musumeci (1999) ArticleTitleLocally advanced breast cancer treated with primary chemotherapy: comparison between magnetic resonance imaging and pathologic evaluation of residual disease Tumori 85 IssueID4 220–228 Occurrence Handle1:STN:280:DC%2BD3c%2Flt1ejtg%3D%3D Occurrence Handle10587021
PJ Drew MJ Kerin T Mahapatra C Malone JRT Monson LW Turnbull JN. Fox (2001) ArticleTitleEvaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast European J Surg Oncol 27 IssueID7 617–620 Occurrence Handle10.1053/ejso.2001.1194 Occurrence Handle1:STN:280:DC%2BD3MrmslWhug%3D%3D
AR. Padhani (2002) ArticleTitleFunctional MRI for anticancer therapy assessment Eur J Cancer 38 IssueID16 2116–2127 Occurrence Handle10.1016/S0959-8049(02)00388-X Occurrence Handle1:STN:280:DC%2BD38njtValtg%3D%3D Occurrence Handle12387837
C Hayes AR Padhani MO. Leach (2002) ArticleTitleAssessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging NMR Biomed 15 IssueID2 154–163 Occurrence Handle10.1002/nbm.756 Occurrence Handle11870911
G Brix W Semmler R Port LR Schad G Layer WJ. Lorenz (1991) ArticleTitlePharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging J Compu Assis Tomogr 15 IssueID4 621–628 Occurrence Handle1:STN:280:DyaK3M3os1Gjtg%3D%3D Occurrence Handle10.1097/00004728-199107000-00018
P Therasse SG Arbuck EA Eisenhauer J Wanders RS Kaplan L Rubinstein J Verweij M Glabbeke ParticleVan AT Oosterom ParticleVan MC Christian SG. Gwyther (2000) ArticleTitleNew guidelines to evaluate the response to treatment in solid tumors J Nat Cancer Ins 92 IssueID3 205–216 Occurrence Handle10.1093/jnci/92.3.205 Occurrence Handle1:STN:280:DC%2BD3c7it1Gitg%3D%3D
JM Bland DG. Altman (1986) ArticleTitleStatistical-methods for assessing agreement between 2 methods of clinical measurement Lancet 1 IssueID8476 307–310 Occurrence Handle1:STN:280:DyaL287hslWqsQ%3D%3D Occurrence Handle2868172
ML George ASK Dzik-Jurasz AR Padhani G Brown DM Tait SA Eccles RI. Swift (2001) ArticleTitleNon-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer Br J Surg 88 IssueID12 1628–1636 Occurrence Handle10.1046/j.0007-1323.2001.01947.x Occurrence Handle1:STN:280:DC%2BD3MnptlansQ%3D%3D Occurrence Handle11736977
Padhani AR, Hayes C, Assersohn L, Powles TJ, Leach MO, Husband JE: Response of breast carcinoma to chemotherapy – MR permeanbility changes using histogram analysis. Proceedings of the 8th International Society for Magnetic Resonance in Medicine. Denver, April 1–7 2000, p 2160
K Wasser SK Klein C Fink H Junkermann HP Sinn I Zuna MV Knopp S. Delorme (2003) ArticleTitleEvaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution Eur Radiol 13 IssueID1 80–87 Occurrence Handle1:STN:280:DC%2BD3s%2FjtlKiug%3D%3D Occurrence Handle12541113
JP Delille PJ Slaneta ED Yeh EF Halpern DB Kopans L. Garrido (2003) ArticleTitleInvasive ductal breast carcinoma response to neoadjuvant chemotherapy: Noninvasive monitoring with functional MR imaging – Pilot study Radiology 228 IssueID1 63–69 Occurrence Handle12775851
H Hawighorst MV Knopp J Debus U Hoffmann M Grandy J Griebel I Zuna M Essig SO Schoenberg A Vries ParticleDe G Brix GV. Kaick (1998) ArticleTitlePharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: initial results J Magn Reson Imaging 8 IssueID4 783–788 Occurrence Handle1:STN:280:DyaK1czms1Cgug%3D%3D Occurrence Handle9702878
JA Loncaster BM Carrington JR Sykes AP Jones SM Todd R Cooper DL Buckley SE Davidson JP Logue RD Hunter CML West (2002) ArticleTitlePrediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix Int J Radiat Oncol Biol Phy 54 IssueID3 759–767 Occurrence Handle10.1016/S0360-3016(02)02972-3
Ah-See MW, Taylor NJ, Makris A, Burcombe J, Stirling JJ, Cladd HJ, Leach MO, Padhani A: Preliminary evaluation of multi-functional MRI to predict response to neoadjuvant chemotherapy in primary breast cancer. American Society of Clinical Oncology 39th Annual Meeting, Chicago, 31 May-3 June 2003, p 556
Ah-See MW, Makris A, Taylor NJ, Harrison M, Richman P, Arcy JAD, Burcombe RJ, Pittam MR, Ravichandran D, Stirling JJ, Cladd HJ, Leach MO, Padhani AR: Multi-functional magnetic resonance imaging predicts for clinico-pathological response to neoadjuvant chemotherapy in primary breast cancer. 26th Annual San Antonio Breast Cancer Symposium, San Antonio, 3–6 December 2003, p 252
SM Galbraith RJ Maxwell MA Lodge GM Tozer J Wilson NJ Taylor JJ Stirling L Sena AR Padhani GJS Rustin (2003) ArticleTitleCombretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging J Clin Oncol 21 IssueID15 2831–2842 Occurrence Handle10.1200/JCO.2003.05.187 Occurrence Handle1:CAS:528:DC%2BD2cXpsVKjsb8%3D Occurrence Handle12807936
Y Yamashita T Baba Y Baba R Nishimura S Ikeda M Takahashi H Ohtake H Okamura (2000) ArticleTitleDynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy Radiology 216 IssueID3 803–809 Occurrence Handle1:STN:280:DC%2BD3cvktValsQ%3D%3D Occurrence Handle10966715
K Wasser HP Sinn C Fink SK Klein H Junkermann HP Ludemann I Zuna S Delorme (2003) ArticleTitleAccuracy of tumor size measuremen in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy Eur Radiol 13 IssueID6 1213–1223 Occurrence Handle1:STN:280:DC%2BD3s3ktFajtw%3D%3D Occurrence Handle12764635
HJ Knowles AL Harris (2001) ArticleTitleHypoxia and oxidative stress in breast cancer – Hypoxia and tumourigenesis Breast Cancer Res 3 IssueID5 318–322 Occurrence Handle10.1186/bcr314 Occurrence Handle1:CAS:528:DC%2BD3MXntlegsLo%3D Occurrence Handle11597321
CW Pugh J Gleadle PH Maxwell (2001) ArticleTitleHypoxia and oxidative stress in breast cancer – Hypoxia signalling pathways Breast Cancer Res 3 IssueID5 313–317 Occurrence Handle10.1186/bcr313 Occurrence Handle1:CAS:528:DC%2BD3MXntlegsLw%3D Occurrence Handle11597320
TN Seagroves HE Ryan H Lu BG Wouters M Knapp P Thibault K Laderoute RS Johnson (2001) ArticleTitleTranscription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells Mol Cell Biol 21 IssueID10 3436–3444 Occurrence Handle10.1128/MCB.21.10.3436-3444.2001 Occurrence Handle1:CAS:528:DC%2BD3MXjtF2jsb0%3D Occurrence Handle11313469
JA Loncaster BM Carrington JR Sykes AP Jones SM Todd R Cooper DL Buckley SE Davidson JP Logue RD Hunter CML West (2002) ArticleTitlePrediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix Int J Radiat Oncol Biol Phys 54 IssueID3 759–767 Occurrence Handle10.1016/S0360-3016(02)02972-3 Occurrence Handle12377328
PM Gullino FH Grantham SH Smith (1965) ArticleTitleThe interstitial water space of tumours Cancer Res 25 727–731 Occurrence Handle1:STN:280:DyaF2M7lt1CktQ%3D%3D Occurrence Handle14347560
I Jakobsen H Lyng O Kaalhus EK Rofstad (1995) ArticleTitleMRI of human tumor xenografts In-Vivo – proton relaxation-times and extracellular tumor volume Magn Reson Imaging 13 IssueID5 693–700 Occurrence Handle10.1016/0730-725X(95)00019-D Occurrence Handle1:STN:280:DyaK287gsFyqtA%3D%3D Occurrence Handle8569443
S Mussurakis DL Buckley A Horsman (1997) ArticleTitleDynamic MRI of invasive breast cancer: assessment of three region-of-interest analysis methods J Comput Assist Tomogr 21 IssueID3 431–438 Occurrence Handle10.1097/00004728-199705000-00017 Occurrence Handle1:STN:280:DyaK2s3otFentw%3D%3D Occurrence Handle9135653
GP Liney P Gibbs C Hayes MO Leach LW Turnbull (1999) ArticleTitleDynamic contrast-enhanced MRI in the differentiation of breast tumors: user-defined versus semi-automated region-of-interest analysis J Magn Reson Imaging 10 IssueID6 945–949 Occurrence Handle10.1002/(SICI)1522-2586(199912)10:6<945::AID-JMRI6>3.0.CO;2-I Occurrence Handle1:STN:280:DC%2BD3c%2FltVemtA%3D%3D Occurrence Handle10581507
MY Su YC Cheung JP Fruehauf H Yu O Nalcioglu E Mechetner A Kyshtoobayeva SC Chen S Hsueh CE McLaren YL Wan (2003) ArticleTitleCorrelation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer J Magn Reson Imaging 18 IssueID4 467–477 Occurrence Handle10.1002/jmri.10380 Occurrence Handle14508784
DL Buckley PJ Drew S Mussurakis JRT Monson A Horsman (1997) ArticleTitleMicrovessel density in invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI J Magn Reson Imaging 7 IssueID3 461–464 Occurrence Handle1:STN:280:DyaK2szhtlKhtA%3D%3D Occurrence Handle9170027
CK Kuhl (2000) ArticleTitleMRI of breast tumors Eur Radiol 10 IssueID1 46–58 Occurrence Handle10.1007/s003300050006 Occurrence Handle1:STN:280:DC%2BD3c7jtVyksw%3D%3D Occurrence Handle10663717
C Boetes SP Strijk R Holland JO Barentsz RF VanderSluis JHJ Ruijs (1997) ArticleTitleFalse-negative MR imaging of malignant breast tumors Eur Radiol 7 IssueID8 1231–1234 Occurrence Handle10.1007/s003300050281 Occurrence Handle1:STN:280:DyaK1c%2Fis1alsA%3D%3D Occurrence Handle9377507
PB. Tofts (2003) Quantitative MRI of the Brain John Wiley & Sons Ltd Chichester 341–364
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pickles, M.D., Lowry, M., Manton, D.J. et al. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 91, 1–10 (2005). https://doi.org/10.1007/s10549-004-5819-2
Issue Date:
DOI: https://doi.org/10.1007/s10549-004-5819-2